“The company has secured marketing authorisation from Serbia for gemcitablne and docetaxel, widely used chemotherapy drugs beneficial in the treatment of various types of cancer,” the company said in a regulatory filing.
“The company has secured marketing authorisation from Serbia for gemcitablne and docetaxel, widely used chemotherapy drugs beneficial in the treatment of various types of cancer,” the company said in a regulatory filing. “The company has secured marketing authorisation from Serbia for gemcitablne and docetaxel, widely used chemotherapy drugs beneficial in the treatment of various types of cancer,” the company said in a regulatory filing. Moneycontrol Latest News Read More
English 
हिन्दी